Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Gaviscon Extra Strength aluminum hydroxide and magnesium carbonate 160 mg; 105 mg Tablet, Chewable, 100-count — NDC 0135-0098-26 (Billing 00135-0098-26)
by Haleon US Holdings LLC · 100 TABLET, CHEWABLE in 1 BOTTLE
This is a package of 100 tablets of Gaviscon Extra Strength aluminum hydroxide and magnesium carbonate 160 mg; 105 mg Tablet, Chewable from Haleon US Holdings LLC, marketed since Jun 2011 and currently FDA-listed. It is this product's only package size.
NDC 00135-0098-26
🏷️ FDA NDC (as labeled)
0135-0098-26
billing pads the labeler segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 0135-0098-26 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 0135 labeler · 0098 product · 26 package
- Package marketed since
- Jun 13, 2011
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Billing quantity
- 100 EA per package
- Barcode (UPC-A, from the NDC)
- 3 0135009826 7
- FDA record last changed
- Sep 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
0135-0098-26
Product NDC
0135-0098
11-digit billing NDC
00135009826
NCPDP billing unit
EA — each (per item)
UNII
0E53J927NA, 5QB0T2IUN0
Application #
M001
SPL Set ID
7f367927-c366-465c-a059-e2cfb337d562
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2011-06-13
Route
ORAL
Dosage form
TABLET, CHEWABLE
Substance
ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
48990002150520
GPI class
Gaviscon Extra Strength
GCN Seq No
019663
GCN
64114
HICL code
001173
Ingredient (HICL)
Magnesium Carb/Aluminum Hydrox
HIC1 code
D
Therapeutic class — broad (HIC1)
Biliary System/Gastro-Intestinal System
HIC2 code
D4
Therapeutic class — intermediate (HIC2)
Drugs Acting Principally On The Alimentary Tract
HIC3 code
D4B
Therapeutic class — specific (HIC3)
Antacids
AHFS code
56:04.00.00
AHFS class
Antacids And Adsorbents
FDB label name
GAVISCON ES TABLET CHEW
FDB brand name
Gaviscon
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 019663
- GCN: 64114
- GPI-14 (Medi-Span): 48990002150520
- HICL (First Databank): 001173
- AHFS class code: 56:04.00.00
- RxCUI (RxNorm): 212978
Why two NDCs?
The FDA registers this code as 0135-0098-26 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00135-0098-26. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the Drugs for treatment of hyperkalemia and hyperphosphatemia class.
Drug family (ATC)
Drugs for treatment of hyperkalemia and hyperphosphatemia, Magnesium compounds, Osmotically acting laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Label name GAVISCON ES TABLET CHEW Ingredient Magnesium Carb/Aluminum Hydrox
📗 Our plain-language guide HelloPharmacist
- It relieves acid indigestion, heartburn, sour stomach and upset stomach caused by those symptoms. Mag-AL Liquid is the oral suspension form.
- Shake the bottle well, then measure your dose in teaspoonfuls. Adults and children 12 and older usually take it up to four times a day, or as your doctor directs. Follow the produc...
- Don't take more than 16 teaspoonfuls in 24 hours. Also avoid using the maximum dose for more than 2 weeks unless a doctor is supervising you.
- If your symptoms last more than 2 weeks, stop and check in with a doctor. Ongoing symptoms deserve a proper look.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
💬 Questions about aluminum hydroxide and magnesium carbonate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 8, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00135-0098-26 You're viewing this Main listing | 100 TABLET, CHEWABLE in 1 BOTTLE | 2011-06-13 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Acid Gone Antacid Extra Strength 160 mg/1; 105 mg 00904-5365-60 | Major | 100 tablets | $0.044 | — | Availability likely | — |
| GOOD NEIGHBOR PHARMACY Antacid Extra Strength 160 mg/1; 105 mg 46122-0150-78 | Amerisource | 100 tablets | $0.044 | — | Availability likely | — |
| Extra Strength Antacid Original Flavor 160 mg/1; 105 mg 70000-0234-01 | Cardinal | 100 tablets | $0.044 | — | Availability likely | — |
| Gaviscon Extra Strength 160 mg/1; 105 mgthis 00135-0098-26 | Haleon | 100 tablets | — | — | FDA listed | — |
| Gaviscon Extra Strength 160 mg/1; 105 mg 00135-0430-03 | Haleon | 100 tablets | — | — | FDA listed | — |
| FAST ACTING Heartburn Relief 160 mg/1; 105 mg 00363-1155-10 | WALGREEN | 100 tablets | — | — | FDA listed | — |
| Extra Strength Antacid 160 mg/1; 105 mg 11673-0814-00 | TARGET | 100 tablets | — | — | FDA listed | — |
| Rite Aid Extra Strength 160 mg/1; 105 mg 11822-1050-00 | RITE | 100 tablets | — | — | FDA listed | — |
| Rite Aid Extra Strength 160 mg/1; 105 mg 11822-1051-00 | RITE | 100 tablets | — | — | FDA listed | — |
| HEB Extra Strength Original Flavor 160 mg/1; 105 mg 37808-0505-10 | HEB | 100 tablets | — | — | FDA listed | — |
| HEB Extra Strength Cherry Flavor 160 mg/1; 105 mg 37808-0510-10 | HEB | 100 tablets | — | — | FDA listed | — |
| Meijer Extra Strength Original Flavor 160 mg/1; 105 mg 41250-0675-10 | MEIJER | 100 tablets | — | — | FDA listed | — |
| equate Extra Strength Antacid 160 mg/1; 105 mg 49035-0105-10 | Wal-Mart | 100 tablets | — | — | FDA listed | — |
| CVS PHARMACY Extra Strength Cherry Flavor 160 mg/1; 105 mg 51316-0155-00 | CVS | 100 tablets | — | — | FDA listed | — |
| CVS Health Extra Strength Heartburn Relief Antacid Original Flavor 160 mg/1; 105 mg 59779-0880-78 | CVS | 100 tablets | — | — | FDA listed | — |
| Extra Strength Antacid Original Flavor 160 mg/1; 105 mg 63868-0996-01 | CHAIN | 100 tablets | — | — | FDA listed | — |
| Premier Value Extra Strength Original Flavor 160 mg/1; 105 mg 68016-0105-10 | PHARMACY | 100 tablets | — | — | FDA listed | — |
| Aluminum hydroxide and Magnesium carbonate 160 mg/1; 105 mg 76457-0001-00 | Simpex | 100 tablets | — | — | FDA listed | — |
| QUALITY CHOICE Original Flavor 160 mg/1; 105 mg 83324-0219-01 | CHAIN | 100 tablets | — | — | FDA listed | — |
| Kroger Extra Strength 160 mg/1; 105 mg 30142-0610-00 | THE | 100 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2011
On the market since
Jun 2011
📍
2026
Currently FDA-listed
15 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
White
ShapeRound
ImprintGAVISCON
Size13 mm
ScoringNot scored
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 8, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Aluminum Hydroxide and Magnesium Hydroxide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 8C3Z4148WZ
Alginic acid is a natural polymer extracted from brown seaweed. In medicines, it acts as a thickener, binder, and disintegrant to help form tablets and control how quickly the medicine dissolves.
-
UNII 776XM7047L
Calcium stearate is a white powder derived from stearic acid and calcium. It works as a lubricant and glidant to help the medicine flow smoothly during manufacturing and prevent ingredients from sticking to equipment.
-
UNII 3OWL53L36A
A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
-
UNII 8MDF5V39QO
A white powder form of baking soda that acts as a buffer and pH regulator in medicines. It helps maintain the right acid-base balance and may aid tablet disintegration.
-
UNII 506T60A25R
Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
-
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
8 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesalginic acid, calcium stearate, flavor, sodium bicarbonate, and sucrose. May contain stearic acid. Contains sorbitol or mannitol. May contain starch. acesulfame k, alginic acid, artificial flavor, calcium stearate, corn starch, corn syrup solids, mannitol, sodium bicarbonate, stearic acid, sucrose
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerHaleon US Holdings LLC
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code00135
First marketedJun 2011
Product typeHuman Otc Drug
Portfolio405 products on file
More NDCs from Haleon US Holdings LLC labeler code 00135
- Tums Ex calcium carbonate 750 mg Tablet NDC 0135-0074-01
- Tums Ex calcium carbonate 750 mg Tablet NDC 0135-0076-01
- Citrucel methylcellulose 2 g/19g Powder, For Solution NDC 0135-0089-69
- Citrucel methylcellulose 2 g/10.2g Powder, For Solution NDC 0135-0090-70
- GAVISCON aluminum hydroxide and magnesium carbonate 95 mg/15mL; 358 mg/15mL Liquid NDC 0135-0094-41
- GAVISCON aluminum hydroxide and magnesium carbonate 254 mg/5mL; 237.5 mg/5mL Liquid NDC 0135-0095-41
- Tums Ultra calcium carbonate 1000 mg Tablet, Chewable NDC 0135-0118-01
- Tums Chewy Bites Mixed Fruit calcium carbonate 1000 mg Tablet, Chewable NDC 0135-0138-03
- Tums Ex calcium carbonate 750 mg Tablet NDC 0135-0140-01
- Tums Ex calcium carbonate 750 mg Tablet NDC 0135-0154-02
- TUMS Extra Strength Sugar-Free calcium carbonate 750 mg Tablet, Chewable NDC 0135-0155-01
- Nicorette Original nicotine polacrilex 2 mg Gum, Chewing NDC 0135-0157-07
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Ask a Doctor or Pharmacist Before Use If
📄 When Using This Product
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses relieves • acid indigestion • heartburn • sour stomach • upset stomach associated with these symptoms
⏱️ Dosage and Administration ▾
Directions • chew 2-4 tablets four times a day or as directed by a doctor • take after meals and at bedtime or as needed • for best results follow by a half glass of water or other liquid • DO NOT SWALLOW WHOLE
⚠️ Warnings ▾
Warnings Ask a doctor or pharmacist before use if you are • taking a prescription drug. Antacids may interact with certain prescription drugs. • if you are on a sodium-restricted diet When using this product • do not take more than 16 tablets in 24 hours • do not use the maximum dosage for more than 2 weeks Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredients (in each tablet) Aluminum hydroxide 160mg Magnesium carbonate 105mg
🧪 Inactive Ingredients ▾
Inactive ingredients (Extra Strength) alginic acid, calcium stearate, flavor, sodium bicarbonate, and sucrose. May contain stearic acid. Contains sorbitol or mannitol. May contain starch.
Inactive ingredients (Extra Strength Cherry) acesulfame k, alginic acid, artificial flavor, calcium stearate, corn starch, corn syrup solids, mannitol, sodium bicarbonate, stearic acid, sucrose
🎯 Purpose ▾
Purpose Antacid Antacid
📄 Ask a Doctor or Pharmacist Before Use If ▾
Ask a doctor or pharmacist before use if you are • taking a prescription drug. Antacids may interact with certain prescription drugs. • if you are on a sodium-restricted diet
📄 When Using This Product ▾
When using this product • do not take more than 16 tablets in 24 hours • do not use the maximum dosage for more than 2 weeks
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions or comments? call toll-free 1-800-452-0051 (English/Spanish) weekdays
📄 Package Label / Principal Display Panel ▾
Principal Display Panel (Extra Strength Original Flavor) Gaviscon ® EXTRA STRENGTH ANTACID • Fast-Acting Heartburn Relief • Helps Keep Acid Down for Hours ORIGINAL FLAVOR 100 Chewable Tablets Trademarks owned or licensed by Haleon. Distributed by: Haleon, Warren, NJ 07059 Made in France ©2024 Haleon or licensor. 215894 – Bottle Label Gaviscon Extra Strength Tablet Original Flavor 100 ct
Principal Display Panel (Extra Strength Cherry Flavor) Gaviscon ® EXTRA STRENGTH ANTACID • Fast-Acting Heartburn Relief • Helps Keep Acid Down for Hours CHERRY FLAVOR 100 Chewable Tablets Gaviscon Extra Strength Tablet Cherry 100 Ct
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Haleon US Holdings LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Haleon US Holdings LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.